Featured News

Vaccine and Infectious Disease Division

Featured News

Laboratories inside the Vaccine and Infectious Disease Division (VIDD), Fred Hutchinson Cancer Research Center

Three Fred Hutch groups receive HIV cure research grants

Three groups of VIDD researchers at Fred Hutchinson Cancer Research Center have received a total of $800,000 in grants to investigate approaches to overcoming the main barrier to an HIV cure: reducing reservoirs of virus that lie dormant in some of the longest-lived cells of the body.

All of the grants — announced on the same day last month — are from the New York-based American Foundation for AIDS Research, or amfAR, as part of its Countdown to a Cure initiative.  Two of the grants, to Drs. Keith Jerome and Hans-Peter Kiem, respectively, will fund research in preclinical models on cell and gene therapies.

The third grant — to Drs. Josh Schiffer and Florian Hladik — will support a small human clinical trial to test whether a drug already approved for another purpose can shrink reservoirs of HIV.

Read entire story >